Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9
|
|
- Gwenda Dina Hubbard
- 5 years ago
- Views:
Transcription
1 Meeting of Bristol Clinical Commissioning Group To be held on Tuesday, 2 July 2013 commencing at 1.30 pm in the BAWA Centre Title: Replacement of the Commissioning Advisory Forum Agenda Item: 9 1 Purpose To propose and seek agreement of the CCG to the replacement of the Commissioning Advisory Forum [CAF] with new treatment policy review arrangements. 2 Background The CAF was established in 2007 in order to support the commissioning decision-making process; identifying local priorities and to develop local commissioning policies for the commissioning of drugs and health care interventions that are not routinely funded across BNSSG. With the commencement of the CCGs on 1 April 2013 and NHS England taking responsibility for many areas of work previously considered by the CAF, a review of the CAF system was undertaken. This paper summarises the key recommendations from that meeting. 3 Discussion of issues Within that ethos, the CAF enabled clinicians to bring forward proposals for new service developments in order to support any funding application put forward to the annual funding round as well as allowing PCT Commissioners to bring forward policies in order to manage access to low priority treatments. The CAF s role in reviewing new treatment and service requests from Clinicians meant that the committee would examine the proposals including the clinical evidence to support such treatments and consider whether they could recommend the development of the services to the local CCGs. Each proposal from a clinician would lead to a policy being drawn together to either allow access to all patients, a restricted group of patients or only allow the treatment to be given in exceptional circumstances. As the financial picture of the NHS has become more challenging in recent years, the CAF was less able to support initiatives which would require significant investment and therefore the link to the annual funding round diminished. However, this is seen as a key area in providing commissioning support to CCGs in future annual funding processes. If you need this document in a different format telephone the PCT on Page 1 of 8
2 The CAF also considered whether to recommend the adoption of policies restricting access to established treatments which are considered to be lower priority. The list of these policies is known as the Interventions Not Normally Funded list or INNF list. It should be noted that the CAF did not have powers to award funding to new service developments and if funding was needed, this would need to be secured through the normal annual funding rounds. Proposals that are cost saving or self-funding were able to be implemented if both the CAF and CCGs had approved the development. The CAF Committee comprised: A GP from each of the three Clinical Commissioning Groups [CCGs] in the BNSSG area, and The Medical Director, Pharmacy Director and Commissioning Manager from both UH Bristol Trust and North Bristol Trust, and a representative from Weston Area Health Trust A Commissioning Manager from each of BNSSG PCTs and A Medicines Management lead, and Public Health Consultants. Key Proposals In considering this issue, it is clear that the conflicting needs of service developments, including new technologies, new medicine uses and policy developments could no longer be effectively managed through one CAF style process. Therefore, it is recommended that each area should be considered by separate bodies. New Uses of Medicines: Previously, proposals for new uses of drugs were considered by the CAF. However, there was traditionally a number of overlaps in the responsibilities of CAF and the Joint Formulary Group and this made the process for having new drug uses confusing for providers. The Executive Summary of the Joint Formulary Group Annual Report for 2012/13 is reproduced in Appendix 1 for information. With the commencement of the CCGs, the remit of the Joint Formulary Group has been reviewed and Public Health support via the Core Offer has been secured, the Joint Formulary is now seen as the vehicle to take forward new drug commissioning. The first recommendation is that the consideration of commissioning drugs should be removed from the remit of the CAF successor and in future all drugs will be considered by the Joint Formulary Group. Discussions have taken place regarding this chance of remit for the Group and changes to that groups Terms of Reference will be taken forward by the Medicines Management team. New Interventions: Historically the CAF was first developed mainly in order to consider the clinical evidence around new service development proposals from the Acute Trusts. This Page 2 of 8
3 ensured that there was a method to review the evidence and to inform the annual financial planning round whether a proposal was clinically effective. However, with the challenging financial position that developed, this element became a lower priority for the Acute Trusts and the PCTs. However a process to review and agree priorities for new service developments is needed by the Trusts and CCGs in order to assess the benefits of proposals. A process is also needed to review new service development proposals ahead of the annual funding process and to ensure that the clinical evidence supports such new developments. New service developments will include proposals where the Trusts are developing a new surgical intervention but it will be used on an existing patient group and will not change the HRG to which they are coded. This group will require the Trusts to consult over all new service developments at the new interventions group, and that if they do not the provider will be liable for any additional financial impact arising from this. This will ensure that the CCGs will have an enhanced level of control over new service developments. The enhancement of the Healthy Futures programme across BNSSG could allow joined up working ensure wider consideration of such proposals. Discussions will take place with the Healthy Futures team to explore this. It is proposed that subject to discussions with the Healthy Futures programme, this body will meet twice per annum. Clinical Policy Review Group - Over the last four years, over 100 clinical policies managing access to treatments for planned care procedures have been agreed and implemented through the CAF process. With persistent pressures on planned care budgets, and an on-going need to review and renew the established policies, it is proposed that a new Policy Review Group be established. The Clinical Policy Review Group will replace the CAF, the remit of the group will be to: Undertake a programme of review of the current BNSSG CCG policies to ensure that they remain appropriate, measured and effective, particularly to confirm that the evidence supporting their initial adoption remains valid. This review will also mean greater exploration of what alternatives for the patients are available if an intervention is not the option in future and wider consideration needs to be given to costs and effects of policies being adopted. Review the evidence to support new policy developments and balance the conflicting demands of evidence to support treatments (which are often long established) against capacity and resource restrictions Review the impact of new policy developments on activity, capacity and resources six months following the implementation of the agreed policies. (Note: implementation of new policies need to be agreed contractually with the Page 3 of 8
4 Acute Trusts and they are allowed one month following the signing of contract variations to implement fully) These activities above will result in recommendations to the BNSSG CCGs around existing and proposed policies and the CCGs will receive these reports jointly from the CCGs Individual Funding Request Leads and the Individual Funding Request Manager of the SWCSU. This group will comprise: Individual Funding Request Leads from each of BNSSG CCGs, with a far greater input from primary care colleagues being desirable, Public Health colleagues (this support is included in the Core Offer), secondary care clinicians with experience of the area being discussed, and public engagement. It is proposed that this group will meet quarterly initially and be administered by the Individual Funding Request team of SWCSU. A Terms of Reference will be developed upon acceptance of this proposal. The TOR will state that the Policy Review Group will make recommendations to the CCGs and they will continue to be approved, or rejected, by the BNSSG CCG Boards. 4 Financial Implications There are no financial implications to this proposal. Each development and policy considered by the new groups will consider the financial impact separately. 5 Legal implications There are no legal issues raised in this paper 6 Risk implications, assessment and mitigation There is no risk envisaged in implementing this recommendation. 7 How have service users, carers and local people been involved? No service users have been specifically consulted on this change but it is proposed to secure wider pubic engagement in the Fora going forward. In addition, there has been wide consultation with former CAF members in developing these proposals. 8 Implications on equalities and health inequalities. There is no impact. 9 How does this fit with Bristol CCG s Annual Work Plan or Strategic Objectives? This proposal allows the CCG to have an open and transparent process for reviewing and adopting new policies and interventions. Page 4 of 8
5 10 Recommendation(s) The Clinical Commissioning Group is asked to: Agree the proposed solution for the replacement of the Commissioning Advisory Forum [CAF], including: o that all proposals for the new uses of medicines and drugs be considered by the Joint Formulary Group, o that a New Interventions Review Group be established jointly with the Healthy Futures programme, o that a new Clinical Policy Review Group be established across BNSSG CCGs to consider and review policies governing access to planned care treatments. Niall Mitchell IFR Manager SWCSU 21 June 2013 Claire Beynon Head of Thresholds Management SWCSU 21 June 2013 Appendices Appendix 1 BNSSG Joint Formulary Group Annual Report Executive Summary Page 5 of 8
6 Appendix 1 BNSSG Joint Formulary Group Report 2012/13 Executive Summary This report outlines the work undertaken by the BNSSG Joint Formulary Group (JFG) during the period April 2012 March 2013, on the back of a significant change in process for managing the entry of new medicines into the BNSSG Joint Formulary, implemented in December The JFG is an operational and decision making subgroup of the BNSSG Drugs and Therapeutics (D&TC) and is responsible for developing, and updating the Joint formulary. It seeks to harmonise working across the sector, reduce duplication of work and deliver benefits in terms of quality, safety and efficiency of medicines use across both primary and secondary care. The JFG membership includes both primary and secondary care NHS staff, comprising of Secondary Care Clinicians, GPs, Pharmacists, nursing, and Public Health. The aim of the Joint Formulary (JF) is to promote safe, effective, and economic prescribing in both primary and secondary care. The BNSSG JF covers prescribing in primary and secondary care, and covers approximately 900,000 population. Obtaining agreement across the interface between primary and secondary care and the subsequent prescribing within the JF promotes a seamless approach to prescribing which will benefit all patients who require medicines, and reduces the need for medicine switching programmes. The BNSSG Joint Formulary group manages all new medicine applications to the JF which up until December 2011, was the remit of the individual trusts D&TCs. This was a significant change in process for all members of the JF. There are many benefits of operating a centralised approach to managing the entry of new medicines within BNSSG; the two significant ones being reducing duplication of work within the area and local clinicians having a consistent set of medicines to prescribe from. The group also manages the Traffic Light Status (TLS) of Formulary medicines (i.e. agreeing where appropriate prescribing responsibility should lie) and also the co-ordinating and signing off of Shared Care Protocols for those medicines that have been given amber status i.e. medicines appropriate for specialist initiation, that may be continued by primary care under appropriate written guidance. The BNSSG JF is hosted on the internet, with access to all, including the public. The website can be viewed at The JFG considered 47 New Drug Requests (NDR) between April 2012 to March New Drug Requests TLS Red 17 Approved TLS Amber 4 TLS Green 6 TLS Blue 1 Awaiting e sign off 3 Page 6 of 8
7 Rejected 14 Withdrawn after consideration 2 NBT submitted 27 NDR of which 6 were rejected and 2 were withdrawn after consideration. UHB submitted 10 applications of which 5 were rejected. WAHT submitted 1 application which was approved. AWP submitted 1 application which was rejected. Primary Care / Dermatology Nurses submitted 5 applications of which 2 were rejected. There were 3 joint applications between NBT and UHB which were approved In December 2012, NICE produced the guidance Developing and updating local Formularies, which included a number of recommendations. This document has been evaluated from a BNSSG Joint Formulary perspective, and it is encouraging to note that we are working well within these recommendations. Nevertheless, there are areas that need to be worked on including formalising an appeals process, improving clinical engagement, and attendance at meetings, and ensuring that our local decision making process is robust considering the current NHS structure changes. It has also been made apparent that identification of the appropriate funding stream for the drug needs to be identified early on in the process. Drugs that would be funded via the PbR excluded non NICE drugs budget have been identified as an area that needs managing, in order to streamline reimbursement of these medicines. A request has been made that this budget is managed in the same manner as the NICE College budget. A further need is for a BNSSG Paediatric Joint Formulary to be produced in the same way as the adult formulary. Work is underway to try and address this within the period. Page 7 of 8
8 Page 8 of 8
Leeds West CCG Governing Body Meeting
Agenda Item: LW2015/115 FOI Exempt: N Leeds West CCG Governing Body Meeting Date of meeting: 4 vember 2015 Title: Delegated Commissioning of Primary Medical Services Lead Governing Body Member: Dr Simon
More informationBristol, North Somerset and South Gloucestershire Clinical Commissioning Group Governing Body Meeting In- Common
Bristol, North Somerset and South Gloucestershire Clinical Commissioning Group Governing Body Meeting In- Common Date: Tuesday, 5 th December 2017 Time: 13.30 Location: Vassall Centre. Gill Avenue, Fishponds,
More informationBNSSG CCG Governing Body Meeting
Meeting Date: Tuesday 1st May 2018 Time: 1.30pm Location: The Winter Gardens Pavilions, Weston College, 2 Royal Parade, Weston Super Mare BS23 1AJ Agenda item: 7.2 Report title: Options appraisal for re-procurement
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Access to Drugs Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Access to Drugs Policy Version No.: 3.0 Effective From: 25 January 2016 Expiry Date: 25 January 2019 Date Ratified: 4 November 2015 Ratified By: Medicines
More informationMeeting of Bristol Clinical Commissioning Group Governing Body. Title: Bristol CCG Management of Serious Incidents Agenda Item: 17
Meeting of Bristol Clinical Commissioning Group Governing Body To be held on Tuesday 22 December 2015 commencing at 13:30 at the Greenway Centre, Doncaster Road, Bristol, BS10 5PY Title: Bristol CCG Management
More informationNHS England (Wessex) Clinical Senate and Strategic Networks. Accountability and Governance Arrangements
NHS England (Wessex) Clinical Senate and Strategic Networks Accountability and Governance Arrangements Version 6.0 Document Location: This document is only valid on the day it was printed. Location/Path
More informationNurse prescribing in substance misuse February 2005, updated May 2005
Nurse prescribing in substance misuse February 2005, updated May 2005 1. Introduction This briefing aims to clarify the current situation in relation to nurse prescribing in the substance misuse sector.
More informationHealth Board Report SOCIAL SERVICES AND WELL-BEING ACT (WALES) 2014: REVISED REGIONAL IMPLEMENTATION PLAN
Agenda Item 3.3 27 JANUARY 2016 Health Board Report SOCIAL SERVICES AND WELL-BEING ACT (WALES) 2014: REVISED REGIONAL IMPLEMENTATION PLAN Executive Lead: Director of Planning & Performance Author: Assistant
More informationFront Door Streaming to Primary Care Hub Pilot DRAFT GOVERNANCE FRAMEWORK.
Front Door Streaming to Primary Care Hub Pilot DRAFT GOVERNANCE FRAMEWORK. Created: 13.9.16 Created by: Becca Robinson - Service Improvement Lead Bristol CCG Version: Draft v0.5 Last Review: Next Reviewed
More informationWig and Hair Replacement Policy
Leeds CCGs Wigs and Hair Replacement Policy 2016-19 Wig and Hair Replacement Policy Version: 2016-19 Ratified by: NHS Leeds West CCG Assurance Committee on; 16 vember 2016 NHS Leeds rth CCG Governance
More informationMEETING OF THE GOVERNING BODY IN PUBLIC 7 January 2014
MEETING OF THE GOVERNING BODY IN PUBLIC 7 January 2014 Title: Bedfordshire and Milton Keynes Healthcare Review: The way forward Agenda Item: 4 From: Jane Meggitt, Director of Communications and Engagement
More informationAdults and Safeguarding Committee 19 March Implementing the Care Act 2014: Carers; Prevention; Information, Advice and Advocacy.
Adults and Safeguarding Committee 19 March 2015 Title Report of Wards Implementing the Care Act 2014: Carers; Prevention; Information, Advice and Advocacy Dawn Wakeling (Adult and Health Commissioning
More informationNorth School of Pharmacy and Medicines Optimisation Strategic Plan
North School of Pharmacy and Medicines Optimisation Strategic Plan 2018-2021 Published 9 February 2018 Professor Christopher Cutts Pharmacy Dean christopher.cutts@hee.nhs.uk HEE North School of Pharmacy
More informationProcess and methods Published: 23 January 2017 nice.org.uk/process/pmg31
Evidence summaries: process guide Process and methods Published: 23 January 2017 nice.org.uk/process/pmg31 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationLondon Councils: Diabetes Integrated Care Research
London Councils: Diabetes Integrated Care Research SUMMARY REPORT Date: 13 th September 2011 In partnership with Contents 1 Introduction... 4 2 Opportunities within the context of health & social care
More informationShared Care Agreements for Medicines
Shared Care Agreements for Medicines Author: Scott Garden, Chief Pharmacist, Acute Services Version: 1.0 Authorised by: NHS Fife Area Drug and Therapeutics Committee Date of Authorisation: Review Date:
More informationJoint framework: Commissioning and regulating together
With support from NHS Clinical Commissioners Regulation of General Practice Programme Board Joint framework: Commissioning and regulating together A practical guide for staff January 2018 Publications
More informationVELINDRE NHS TRUST. Trust Procedure PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE
Clinical Excellence (NICE) Guidance VELINDRE NHS TRUST Trust Procedure Black 21 PROCEDURE FOR THE IMPLEMENTATION OF NATIONAL INSTITUTE OF HEALTH & CLINICAL EXCELLENCE (NICE) GUIDANCE Lead: Lisa Heydon-Mann
More informationCLINICAL COMMISSIONING GROUP RESPONSIBILITIES TO ENSURE ROBUST SAFEGUARDING AND LOOKED AFTER CHILDREN ARRANGEMENTS
MEETING DATE: 14 March 2013 AGENDA ITEM NUMBER: Item 8.6 AUTHOR: JOB TITLE: DEPARTMENT: Sarah Glossop Designated Nurse Safeguarding Children NHS North Lincolnshire Clinical Commissioning Group REPORT TO
More informationCCG authorisation: the role of medicines management
May 2012 The NHS medicines bill for 2010 was 12.9 billion, of which secondary care costs accounted for 32%. Prescribing inflation in 2010 ran at 4.8% and it is estimated that around 14% of total CCG budgets
More informationSPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY
SPONSORSHIP AND JOINT WORKING WITH THE PHARMACEUTICAL INDUSTRY 1 SUMMARY This document sets out Haringey Clinical Commissioning Group policy and advice to employees on sponsorship and joint working with
More informationNHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP CLINICAL FUNDING AUTHORISATION POLICY
NHS ISLE OF WIGHT CLINICAL COMMISSIONING GROUP CLINICAL FUNDING AUTHORISATION POLICY AUTHOR/ APPROVAL DETAILS & VERSION CONTROL Author Version Reason for Change Date Status IW CCG Acute V1 New policy Sept
More informationIslington CCG Commissioning Statement in relation to the commissioning of health services for children and young people 0-18 years
Islington CCG Commissioning Statement in relation to the commissioning of health services for children and young people 0-18 years Introduction 1. Islington CCG funds a range of health services for children
More informationA meeting of NHS Bromley CCG Governing Body 25 May 2017
South East London Sector A meeting of NHS Bromley CCG Governing Body 25 May 2017 ENCLOSURE 4 SOUTH EAST LONDON 111 AND GP OUT OF HOURS MEMORANDUM OF UNDERSTANDING SUMMARY: The NHS England Commissioning
More informationGeneral Practice Commissioning Strategy Development
General Practice Commissioning Strategy Development Katharine Denton (Wandsworth CCG) 3 December 2014 Version 5. 03.12.2014 1 1. Introduction Strong General Practice is at the heart of any high quality
More informationAppendix 5.5. AUTHOR & POSITION: Jill Shattock, Director of Commissioning CONTACT DETAILS:
Appendix 5.5 MEETING: Haringey Clinical Commissioning Group Governing Body Meeting DATE Wednesday, 30 July 2014 TITLE: North Central London (NCL) NHS 111 and GP Out of Hours LEAD GOVERNING Jill Shattock,
More informationDeveloping primary care in Barnet
Developing primary care in Barnet Introduction In January 2012, the Joint Boards of NHS North Central London (NCL) approved a NCL Primary Care Strategy, which describes development of the primary care
More informationMeeting of Governing Body
Meeting of Governing Body Date: 7 August 2018 Time: 1.30pm Location: Clevedon Hall, Elton Rd, Clevedon, North Somerset, BS21 7RQ Agenda number: 10.3 Report title: Business Continuity Policy Report Author:
More information5. Does this paper provide evidence of assurance against the Governing Body Assurance Framework?
Item Number: 6.3 Governing Body Meeting: 4 February 2016 Report Sponsor Anthony Fitzgerald Director of Strategy and Delivery Report Author Anthony Fitzgerald Director of Strategy and Delivery 1. Title
More informationMethods: Commissioning through Evaluation
Methods: Commissioning through Evaluation NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Commissioning Strategy
More informationA meeting of Bromley CCG Primary Care Commissioning Committee 22 March 2018
A meeting of Bromley CCG Primary Care Commissioning Committee 22 March 2018 ENCLOSURE 7 PROPOSAL FOR ENHANCED MEDICAL SUPPORT TO BROMLEY CARE HOMES SUMMARY: Bromley CCG gained agreement at the CCG Clinical
More informationMEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY
MEDICINES STANDARD B3: WORKING WITH THE PHARMACEUTICAL INDUSTRY NHS employees and contractors link with the pharmaceutical industry in a number of ways, as a source of information, through the receipt
More informationINTEGRATION TRANSFORMATION FUND
MEETING DATE: 12 December 2013 AGENDA ITEM NUMBER: Item 6.6 AUTHOR: JOB TITLE: DEPARTMENT: Caroline Briggs Director of Commissioning NHS North Lincolnshire Clinical Commissioning Group REPORT TO THE CLINICAL
More informationThis paper explains the way in which part of the system is changing to become clearer and more accessible, beginning with NHS 111.
Unscheduled care in Haringey 1. Introduction There have been many changes to urgent, unscheduled and unplanned care over recent years. To begin with Casualty departments became Accident and Emergency departments,
More informationNHS East and North Hertfordshire Clinical Commissioning Group. Quality Committee. Terms of Reference Version 4.0
NHS East and North Hertfordshire Clinical Commissioning Group Quality Committee Terms of Reference Version 4.0 1. Introduction 1.1 The Quality Committee (the committee) is established in accordance with
More informationPrimary Care Commissioning Next Steps to Delegated Commissioning September Board Paper. 2.0 Delegated Opportunities, Benefits and Risks
Primary Care Commissioning Next Steps to Delegated Commissioning September Board Paper 1.0 Introduction This paper provides a briefing to the Wandsworth CCG Board on our progress in developing a Primary
More informationabcdefghijklmnopqrstu
Healthcare Policy and Strategy Directorate Quality Division Dear Colleague INTRODUCTION AND AVAILABILITY OF NEWLY LICENSED MEDICINES IN THE NHS IN SCOTLAND Dear Colleague This guidance sets out the policy
More informationGOVERNING BODY MEETING in Public 27 September 2017 Agenda Item 5.2
GOVERNING BODY MEETING in Public 27 September 2017 Paper Title Report Author Neil Evans Turnaround Director Referral Management s Contributors John Griffiths Date report submitted 20 September 2017 Dean
More informationQUALITY COMMITTEE. Terms of Reference
QUALITY COMMITTEE Terms of Reference This Committee will report to NHS Halton CCG Governing Body on the development, improvement and monitoring of all areas of quality. This will include clinical effectiveness,
More informationFOI Summary Issue Avon and Wiltshire Mental Health Partnership NHS Trust (AWP)
FOI 1415-0038 Summary Issue Avon and Wiltshire Mental Health Partnership NHS Trust (AWP) This information related to South Gloucestershire Clinical Commissioning Group Question 1. I am interested in receiving
More informationSpecialised Commissioning Oversight Group. Terms of Reference
Specialised Commissioning Oversight Group Terms of Reference Specialised commissioning oversight group terms of reference 1 1.1 Purpose NHS England is responsible for commissioning specialised services
More informationAny Qualified Provider: your questions answered
Any Qualified Provider: your questions answered September 8, 2011 These answers cover a range of questions about the detail of Any Qualified Provider on integrated care, competition and procurement, liability
More informationRegional Medicines Optimisation Committees
Regional Medicines Optimisation Committees Operating Model First Edition, April 2017 NHS England INFORMATION READER BOX Directorate Medical Commissioning Operations Patients and Information Nursing Trans.
More informationUrgent Primary Care Update Paper
Urgent Primary Care Update Paper Primary Care Commissioning Committee meeting D 17 May 2018 Author(s) Sponsor Director Purpose of Paper Kate Gleave Brian Hughes, Director of Commissioning The purpose of
More informationStrategic Commissioning Plan for Primary Care: Hull Primary Care Blueprint
APPENDIX 1: 1. Vision and context The vision for the Blueprint being proposed is consistent with the CCG s Hull 2020 Transformation Programme and the direction of travel and new models of care outlined
More informationUKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
More informationAGENDA ITEM NO: 046/17
AGENDA ITEM NO: 046/17 GOVERNING BODY MEETING: Governing Body Meeting DATE OF MEETING: 13 th September 2017 REPORT AUTHOR AND JOB TITLE: Rebecca Knight Head of Assurance & Risk REPORT TITLE: STRATEGIC
More informationCare Home support and medicines optimisation: Community Pharmacy National Enhanced Service
Care Home support and medicines optimisation: Community Pharmacy National Enhanced Service 1 1. Introduction Back in 2006 the National Service Framework for Older People in Wales 1 highlighted the problem
More informationMedicines Management Guidance
Medicines Management Guidance Status Final Version 1.0 Author Jon Boyd Version date 05/12/2016 Agreed by the following North West London CCGs: Central London West London Hammersmith and Fulham Hounslow
More informationPrimary Care Prescribing Cardiff and Vale University Health Board. Issued: December 2013 Document reference: 447A2013
Primary Care Prescribing Cardiff and Vale University Health Board Issued: December 2013 Document reference: 447A2013 Status of report This document has been prepared for the internal use of Cardiff and
More informationservice users greater clarity on what to expect from services
briefing November 2011 Issue 227 Payment by Results in mental health A challenging journey worth taking Key points Commissioners and providers support the introduction of Payment by Results for adult mental
More informationImproving Mental Health Services in Bath & North East Somerset
Improving Mental Health Services in Bath & North East Somerset Andy Sylvester Executive Director of Operations Welcome & Introductions Housekeeping Format of the day Presentations Questions and answers
More informationClinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session PRIVATE session. Date of Meeting: 24 March 2015
Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session PRIVATE session Date of Meeting: 24 March 205 For: Decision Discussion Noting Agenda Item and title: Author: GOV/5/03/20
More informationNHS Bradford Districts CCG Commissioning Intentions 2016/17
NHS Bradford Districts CCG Commissioning Intentions 2016/17 Introduction This document sets out the high level commissioning intentions of NHS Bradford Districts Clinical Commissioning Group (BDCCG) for
More informationNHS Lanarkshire Policy for the Availability of Unlicensed Medicines
NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:
More informationPrinciples of Shared Care Protocols
Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the
More informationDraft Minutes. Agenda Item: 16
Meeting of Bristol Clinical Commissioning Group Quality and Governance Committee Held on 17th December 2013 At 9:00am in Clinical Commissioning Group Meeting Room Agenda Item: 16 Draft Minutes Present:
More informationNHS DORSET CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING FINANCIAL POSITION AS AT 30TH NOVEMBER C Hickson, Head of Management Accounts
NHS DORSET CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING FINANCIAL POSITION AS AT 30TH NOVEMBER 2013 Date of the meeting 15/01/2014 Author Sponsoring GB member Purpose of report Recommendation Resource
More informationWestminster Health and Wellbeing Board
Westminster Health and Wellbeing Board Date: 13 July 2017 Classification: Title: Report of: Cabinet Member Portfolio: Wards Involved: Policy Context: Report Author and Contact Details: General Release
More informationEAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST
EAST KENT HOSPITALS UNIVERSITY NHS FOUNDATION TRUST REPORT TO: BOARD OF DIRECTORS MEETING DATE: 29 JANUARY 2015 SUBJECT: REPORT FROM: PURPOSE: CQC ACTION PLAN CHAIR OF IMPROVEMENT PLAN DELIVERY BOARD Discussion
More informationEquality and Health Inequalities Strategy
Equality and Health Inequalities Strategy 1 Schematic of the Equality and Health Inequality Strategy Improving Lives: People and Patients Listening and Learning Gaining Knowledge Making the System Work
More informationImproving the prevention, early detection and management of Acute Kidney Injury (AKI) in Wessex
Improving the prevention, early detection and management of Acute Kidney Injury (AKI) in Wessex The case for change AKI is recognised as a major public health and patient safety concern nationally and
More informationDelegated Commissioning Updated following latest NHS England Guidance
Delegated Commissioning Updated following latest NHS England Guidance 13th August 2015 Croydon, Kingston, Merton, Richmond, Sutton and Wandsworth NHS Clinical Commissioning Groups and NHS England (Direct
More informationPrescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services
Prescribing Policy between Nottinghamshire Commissioning Organisations and local providers of NHS Services Document Purpose Version 2.2 To detail the specific contractual issues associated with prescribing
More informationabcdefghijklmnopqrstu
Directorate for Chief Medical Officer, Public Health and Sport Sir Harry Burns, MPH FRCS (Glas) FRCP(Ed) FFPH Health and Social Care Directorate Pharmacy and Medicines Division Professor Bill Scott, MSc,
More informationNHS WOLVERHAMPTON CLINICAL COMMISSIONING GROUP CONSTITUTION
NHS WOLVERHAMPTON CLINICAL COMMISSIONING GROUP CONSTITUTION Version: [78] NHS England Effective Date: 1 December 2015 April 2017 CONTENTS Part Description Page Foreword 1 1 Introduction and Commencement
More informationOFFICIAL. Commissioning a Functionally Integrated Urgent Care Access, Treatment and Clinical Advice Service
Our Ref: BH/2015/253 Publications Gateway Ref. No. 03568 NHS England Quarry House Quarry Hill Leeds LS2 7UE Email : england.nhs111@nhs.net To: CCG Accountable Officers CCG Clinical Leaders Cc: Regional
More informationTrust Board Meeting 05 May 2016
Trust Board Meeting 05 May 2016 Title of the paper: Sustainability and Transformation Plan (STP) Update Agenda item: 15/37 Lead Executive: Trust objective: Purpose: Link to Board Assurance Framework (BAF)
More informationDraft Commissioning Intentions
The future for Luton s primary care services Draft Commissioning Intentions 2013-14 The NHS will have less money to spend over the next three years. Overall, it has to make 20 billion of efficiency savings
More informationCCG Policy for Working with the Pharmaceutical Industry
CCG Policy for Working with the Pharmaceutical Industry 1. Introduction Medicines are the most frequently and widely used NHS treatment and account for over 12% of NHS expenditure. The Pharmaceutical Industry
More informationSt. Helens Safeguarding Standards for GP Practices. Protected Learning Event September 28 th 2011
St. Helens Safeguarding Standards for GP Practices Protected Learning Event September 28 th 2011 2 St Helens Safeguarding Standard: General Practice This document provides an outline of the content of
More informationLooked After Children Annual Report
Looked After Children Annual Report Reporting period April 2016 March 2017 Authors Maxine Lomax - Designated Nurse for Child Protection & Looked After Children Dr. Bin Hooi Low - Designated Doctor for
More informationQuality Assurance Framework. Powys thb provided and commissioned services Quality and Safety Committee November 2013
Quality Assurance Framework Powys thb provided and commissioned services Quality and Safety Committee November 2013 1 Background Together for Health vision for NHS Wales 6 domains of quality Effectiveness
More informationEngland. Questions and Answers. Draft Integrated Care Provider (ICP) Contract - consultation package
England Questions and Answers Draft Integrated Care Provider (ICP) Contract - consultation package August 2018 Questions and Answers Draft Integrated Care Provider (ICP) Contract - consultation package
More informationReview of Terms of Reference of Quality Assurance Committee
Review of Terms of Reference of Quality Assurance Committee Governing Body meeting 3 May 2018 H Author(s) Sponsor Director Purpose of Paper Sue Laing, Corporate Services Risk and Governance Manager Mandy
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT 1. Date of Governing Body Meeting: 2. Title of Report: Chief Executive Officer s Business Report 3. Key Messages: This report provides an overview of important clinical commissioning
More informationBristol CCG Staff Structure March 2017
Bristol CCG Staff Structure March 2017 Teams 1. Corporate Overall Structure 2. Corporate Localities CCG posts 3. Corporate Provider Management Joint posts with Public Health departments 4. Provider Management
More informationThe Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts
The Integrated Support and Assurance Process (ISAP): guidance on assuring novel and complex contracts Part A: Introduction Published by NHS England and NHS Improvement August 2017 First published: Friday
More informationGOVERNING BODY REPORT
GOVERNING BODY REPORT Date of Governing Body Meeting: Title of Report: Key Messages: Finance, Performance and Commissioning Committee Report At the end of September 2017 we have reported an inyear deficit
More informationWELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING
AGENDA ITEM 2.5 28 January 2014 WELSH AUDIT OFFICE REPORT ON PRIMARY CARE PRESCRIBING Lead Responsibility: Medical Director Author: Clinical Board Pharmacist, Primary Community Intermediate Care Clinical
More informationWORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0
WORKING WITH THE PHARMACEUTICAL INDUSTRY POLICY Version 1.0 1 Standard Operating Procedure St Helens CCG Working with The Pharmaceutical Industry Policy Version 1.0 Implementation Date May 2017 Review
More informationQUALITY IMPROVEMENT COMMITTEE
: 2016-002.a QUALITY IMPROVEMENT COMMITTEE Minutes of the meeting held on 11 th February 2016, Conference Room D, 1829 Building Present: Faulkner, Sarah (SF) (Chair) Lay Member, NHS West Cheshire CCG Cavanagh,
More informationMental Health (Wales) Measure Implementing the Mental Health (Wales) Measure Guidance for Local Health Boards and Local Authorities
Mental Health (Wales) Measure 2010 Implementing the Mental Health (Wales) Measure 2010 Guidance for Local Health Boards and Local Authorities Januar y 2011 Crown copyright 2011 WAG 10-11316 F6651011 Implementing
More informationAppendix 1: Integrated Urgent Care Service Update. 1. Purpose
Appendix 1: Integrated Urgent Care Service Update 1. Purpose The purpose of this paper is to provide Governing Body members across the collaborative CCGs with an update on the progress of the Integrated
More informationWOLVERHAMPTON CLINICAL COMMISSIONING GROUP. Corporate Parenting Board. Date of Meeting: 23 rd Feb Agenda item: ( 7 )
WOLVERHAMPTON CLINICAL COMMISSIONING GROUP Corporate Parenting Board Agenda Item No. 7 Health Services for Looked After Children Annual Report September 2014 -August 2015 Date of Meeting: 23 rd Feb 2016.
More informationBIRMINGHAM CITY COUNCIL
BIRMINGHAM CITY COUNCIL PUBLIC REPORT Report to: CABINET Report of: Strategic Director for People Date of Decision: 28 th June 2016 SUBJECT: STRATEGY AND PROCUREMENT PROCESS FOR THE PROVISION OF EARLY
More informationDelivering Local Health Care
Delivering Local Health Care Accelerating the pace of change Contents Joint foreword by the Minister for Health and Social Services and the Deputy Minister for Children and Social Services Foreword by
More informationPEC meeting Patient and Public. Quality and Governance meeting Quarterly from August PEC meeting
Appendix 3 PPI strategy Bristol CCG Patient and Public Involvement (PPI) Action Plan 2014/15 To be read in conjunction with the CCG Equality and Diversity Action Plan, and Communications Action Plan Strategic
More informationSouth Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting
South Gloucestershire Clinical Commissioning Group Improving the Patient Experience Forum Meeting Date: 8 th February 2017 Time: 10am-12:30pm Location: The Batch, Warmley, Bristol MINUTES IPEF members
More informationR&D Forum Response to NHS England Research Strategy Consultation
R&D Forum Response to NHS England Research Strategy Consultation 1. INTRODUCTION January 30 th 2014 NHS England (NHSE) published their draft Research Strategy Research is everybody s business 2013-2018,
More informationTERMS OF REFERENCE. Transformation and Sustainability Committee. One per month (Second Thursday) GP Board Member (Quality) Director of Commissioning
TERMS OF REFERENCE Committee: Frequency Of Meetings: Committee Chair: Membership: Attendance: Lead Officer: Secretary: Transformation and Sustainability Committee One per month (Second Thursday) GP Board
More informationBristol CCG North Somerset CGG South Gloucestershire CCG. Draft Commissioning Intentions for 2017/2018 and 2018/2019
Bristol CCG North Somerset CGG South Gloucestershire CCG Draft Commissioning Intentions for 2017/2018 and 2018/2019 Programme Area Key intention Primary and community care Sustainable primary care Implement
More information1. Title of Paper: NHS Vale of York CCG Local Enhanced Services (LES) Review
Item Number: 6 NHS VALE OF YORK CLINICAL COMMISSIONING GROUP GOVERNING BODY MEETING Meeting Date: 5 September 2013 Report Sponsor: Rachel Potts Chief Operating Officer Report Author: Melanie Cooper and
More informationIs Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better?
Is Our South East London Area Prescribing Committee Working To Best Practice, Or Could We Be Even Better? Vanessa Burgess, Assistant Director, Medicines & LTCs, NHS Lambeth Clinical Commissioning Group;
More informationJOB DESCRIPTION. Pharmacy Technician
JOB DESCRIPTION Pharmacy Technician Issued by AT Medics Primary Care Pharmacy Technician Job Description Job Title: Reporting to: Location: Salary: Job status: Contract: Notice Period: Primary care pharmacy
More informationNon-Medical Prescribing Strategy
Non-Medical Prescribing Strategy 2014-2017 Nursing & Partnerships Directorate Page 1 of 13 Section Contents Page No. 1. STATEMENT OF INTENT 3 2. PURPOSE 3 3. SCOPE 3 4. BACKGROUND 3 5. STRATEGIC GOALS
More informationMERTON CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMISSIONING COMMITTEE. Purpose of Report: For Note
Date of Meeting: 23 rd March 2017 MERTON CLINICAL COMMISSIONING GROUP PRIMARY CARE COMMISSIONING COMMITTEE Agenda No: 7 Attachment: 6 Title of Document: Primary Care Strategy Update Purpose of Report:
More informationClinical Commissioning Group (CCG) Board
Clinical Commissioning Group (CCG) Board Date of Meeting: 18 TH May 2012 Agenda Item: Paper 12 Subject: Reporting Officer: Strategic Joint commissioning Options - Adult Care a discussion paper Sheila Downey-
More informationGuidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products
Title: Identifier: Guidance For Health Care Staff Within NHS Grampian On Working With The Pharmaceutical Industry And Suppliers Of Prescribable Health Care Products NHSG/guid/PharmInd/GMMG/738 Replaces:
More informationClinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session PRIVATE session
Clinical Commissioning Group Governing Body Paper Summary Sheet For: PUBLIC session PRIVATE session Date of Meeting: Tuesday 23 September 2014 For: Decision Discussion Noting Agenda Item and title: Author:
More information